- Filed
- Apr 22, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 538.18M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $12.31B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $11.13B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.17B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.92B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $4.46B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $3.84B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.45B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $11.26B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $35.43B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $35.97B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $15.66B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $15.88B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $39.95B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $39.87B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 555.9M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $21M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $835M |
| Capex | Q1 2025 · Mar 31, 2024 | $375M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $767M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.67 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.67 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.13B |
| Net Income | Q1 2025 · Mar 31, 2024 | $928M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $1.15B |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $3.49B |
| Revenue | Q1 2025 · Mar 31, 2024 | $6.02B |